Endocrine Metabolic and Immune Disorders: Drug Targets (ERA Journal)
Endocrine Metabolic and Immune Disorders: Drug Targets is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.
Endocrine Metabolic and Immune Disorders: Drug Targets issns are issn1: 1871-5303 issn2: 2212-3873.
The fields covered by Endocrine Metabolic and Immune Disorders: Drug Targets as part of the evaluation of Australian university research excellence are:
Immunology Research Rankings (Sub-Field)
Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)
Other ERA-accredited journals supporting the evaluation of the Immunology field include:
- Alergia Astma Immunologia
- Clinical Reviews in Allergy and Immunology
- Current Allergy and Clinical Immunology
- Current Trends in Immunology
- Developmental and Comparative Immunology
- European Journal of Immunology
- Infectious diseases and therapy
- Journal of Asthma and Allergy
- Journal of Dermatological Case Reports
- Journal of Immunoassay and Immunochemistry
- Journal of Neuroimmune Pharmacology
- Journal of Neuroimmunology
- Nature Immunology
- OncoImmunology
- Scandinavian Journal of Immunology
ERA Research Rankings Submenu
- ERA 2018 Outcomes Research Rankings List
- ERA 2018 Research Rankings Analysis
- ERA 2018 Individual University Outcomes List
- ERA List of Research Fields Rankings
- ERA Journal Rankings 2018 List
Latest News and Updates:
- Top 10 Best Australian Universities
- Gender Balance Male-Female Ratio
- ERA 2018 Outcomes Research Rankings List
- University Bachelor Degree Completion Rates
- QS Employability Rankings Australian Universities
- ARWU World Rankings of Australian Universities
- Group of Eight (go8) World Rankings